Quantum Healthcare Limited Stock Price
Last Done:
SGD 9.39
+0.12 (+1.31%)
• Login required for live price
Open: --
High: --
Low: --
Prev Close: --
Login to unlock live stock price, change %, and intraday data.
Login to View
📊 Statistics
- Analyst 1 Year Price Target:
-
- Upside/Downside from Analyst Target:
-
- Broker Call:
-
- Dividend Minimum 3 Year Yield:
0.00%
- EPS Growth Range (1Y):
0-10%
- Net Income Growth Range (1Y):
<0%
- Revenue Growth Range (1Y):
0-10%
-
Upcoming Earnings Date:
-
💰 Dividend History
No dividend history available.
📅 SGX Earnings Announcements for V8Y
Quantum Healthcare Limited (V8Y)
Market: SGX |
Currency: SGD
Address: 745 Lorong 5 Toa Payoh
Quantum Healthcare Limited, together with its subsidiaries, engages in the design, assembly, and distribution of advanced therapeutic solutions for the minimally invasive treatment of complex vascular diseases in Singapore. It operates through Vascular Business, Healthcare Business, Corporate segments. The Vascular Business segment engages in the development, manufacturing, and distribution of medical devices. Its Healthcare Business segments provides dental services. It also offers management consultancy services for healthcare organizations. The company was formerly known as QT Vascular Ltd. and changed its name to Quantum Healthcare Limited in July 2022. Quantum Healthcare Limited was founded in 2005 and is based in Singapore. The company operates as a subsidiary of Quantum Healthcare Limited.
Show more
📈 Quantum Healthcare Limited Historical Chart
🧾 Recent Financial Statement / Corporate annoucement / News
April 10, 2026
Quantum Healthcare Limited: FY2025 Financial Analysis and Investor Outlook Quantum Healthcare Limited, listed on the Singapore Exchange (Catalist), recently released its audited financial statements for the year ended 31 December 2025. The report was accompanied by a disclaimer of opinion…
March 1, 2026
Quantum Healthcare Limited FY2025 Results: Financial Analysis and Investor Takeaways Quantum Healthcare Limited released its unaudited condensed interim financial statements for the fourth quarter and full year ended 31 December 2025. The report provides a detailed look at the Group's…
January 28, 2026
Quantum Healthcare Limited EGM: Detailed Investor Report Quantum Healthcare Limited EGM: Major Share Issuances and Debt Conversion Approved Summary of Key Developments at the Extraordinary General Meeting Quantum Healthcare Limited held its Extraordinary General Meeting (EGM) on 29 December 2025,…
January 2, 2026
Quantum Healthcare Limited Completes Major Debt Conversion and Directors’ Fees Capitalisation Quantum Healthcare Limited Completes Major Debt Conversion and Directors’ Fees Capitalisation Key Points from the Announcement Completion of Major Corporate Actions: Quantum Healthcare Limited has announced the successful completion…
November 28, 2025
Quantum Healthcare Limited Completes Major Share Placement Quantum Healthcare Limited Completes S\$3 Million Share Placement – Major Expansion of Share Base Key Highlights Quantum Healthcare Limited has completed a substantial placement of 2,727,272,800 new ordinary shares. The placement raised an…
November 23, 2025
Key Developments Announced Quantum Healthcare Limited (“the Company”) has received a fresh Listing and Quotation Notice (LQN) from the Singapore Exchange Securities Trading Limited (SGX-ST) for the following proposed corporate actions: Placement of 2,727,272,800 New Ordinary Shares: The Company is…
🔎 View more in SGX corporate News 🔎 View more in SGX Financial statements
📰 Research Reports
usort($results_posts, function($a, $b) {
return get_post_time('U', true, $b) - get_post_time('U', true, $a);
});
?>
No related articles found.
